May 2021

Department

Research in Review

05/20/2021

JCP Editors

Treatment Patterns After EGFR-TKI and Platinum-Based Chemotherapy Discontinuation in Metastatic NSCLC Study results show that immunotherapy is the most common next line of therapy after discontinuation of an...

...

05/20/2021

Journal of Clinical Pathways

Conferences

The 2021 Community Oncology Conference

05/19/2021

JCP Editors

Integrating Palliative Care Into Community Oncology Practice At the virtual 2021 COA Annual Conference, Morvarid Rezaie, DO, HMDC, FACOI, discussed the integration of palliative care into community oncology...

...

05/19/2021

Journal of Clinical Pathways

Column

Trending From ACCC

New Tool Helps Cancer Programs Succeed Under Alternative Payment Models

05/19/2021

The Association of Community Cancer Centers begins an initiative to gain insights from Alternative Payment Models’ (APMs) impact on cancer care, Facilitate collaboration and sharing of experiences between cancer programs and practices related...

The Association of Community...

05/19/2021

Journal of Clinical Pathways

COA Viewpoint

Addressing Disparities in Cancer Care

05/19/2021

Kashyap Patel, MD, chief executive officer, Carolina Blood and Cancer Care Associates

Kashyap Patel, MD, discusses disparities in all aspects of cancer care: access to screening, access to care, the ability to pay for care, and more.

Kashyap Patel, MD, discusses...

05/19/2021

Journal of Clinical Pathways

Editor's Page

Financial Burden—for Patients and the Health Care System

05/19/2021

Winston Wong, PharmD

Winston Wong, PharmD, discusses the articles in this issue, which examine attitudes around financial toxicity as well as the financial burden of specific treatments and services in the growing older adult population.

Winston Wong, PharmD, discusses...

05/19/2021

Journal of Clinical Pathways

Pharma Insights

The Importance of Qualitative Research in Enhancing Understanding of Treatment Decisions, Outcomes, and Value Assessment

05/19/2021

Suepattra G May, MPH, PhD

Meaghan Roach, MPH

Richard Murphy, BA

Suepattra May, MPH, PhD, and colleagues believe upfront qualitative research conducted directly with stakeholders is needed to generate both a baseline understanding of the patient perspective and to identify the appropriate themes and...

Suepattra May, MPH, PhD, and...

05/19/2021

Journal of Clinical Pathways

Feature

Research Reports

Overactive Bladder Health Care Burden in the US Long-Term Care Setting: A Retrospective Cohort Study

05/18/2021

Richard G Stefanacci, DO

Jason Yeaw, MPH

Drishti Shah, PhD

Amy Kincaid, MA

Paul N Mudd Jr, PharmD, MBA

Richard Stefanacci, DO, and colleagues describe and evaluate the population, treatment patterns, HCRU, and costs associated with overactive bladder in the in the US long-term care setting.

Richard Stefanacci, DO, and...

05/18/2021

Journal of Clinical Pathways

Research Reports

Assessing Clinician Attitudes and Beliefs Around Financial Toxicity Screening in Medical Oncology Clinic

05/17/2021

Sylvia T Zhang, MS

Errol J Philip, PhD

Nichole Legaspi

Lucky Ding

Tracy Kuo Lin, MSc, PhD

Hala T Borno, MD

Sylvia Zhang, MS, and colleagues discuss the attitudes, motivation, and experiences of clinicians regarding screening for financial toxicity in a medical oncology clinical setting, identifying potential opportunities for future clinician-led...

Sylvia Zhang, MS, and colleagues...

05/17/2021

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

May 2021

Department

Column

Feature

Current Issue

Special Reports

Subscribe

May 2021 Volume 7

Specialties

Events

Year Round Education

HMP Global Products